Quantcast
Last updated on April 24, 2014 at 14:17 EDT

Latest Clinical trial Stories

2014-04-16 12:29:54

PLYMOUTH MEETING, Pa., April 16, 2014 /PRNewswire/ -- ePharmaSolutions, a leading provider of eClinical solutions announced the results of the initial pilot studies for its patient matching and triaging solution, ReferralPlus(TM), that suggest a significant improvement in match rates for people who are actively searching for clinical trials in which to participate. "We are absolutely thrilled with the results of these pilots and want to thank all of the pharmaceutical companies who helped...

2014-04-16 08:34:21

Clinical Results Open Significant Market Opportunity for BioElectronics Corp. FREDERICK, Md., April 16, 2014 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, announced reports on preliminary results of a randomized, double blind, placebo controlled trial on osteoarthritis of the knee (knee pain) using ActiPatch® Therapy. An abstract on the interim analysis of the osteoarthritis (OA) knee pain study has been accepted by...

2014-04-15 23:12:11

Achieve is conducting a randomized, active and placebo-controlled study to evaluate the efficacy and safety of an experimental drug for preventing flares and reducing serum uric acid in patients with gout. Birmingham, AL (PRWEB) April 15, 2014 *To see if you qualify for this Gout Clinical Trial in Birmingham, visit Achieve Clinical Research on the web (http://www.achieveclinical.com/) or contact us directly at (205) 380-6434. There is no cost to participate, no insurance is required, and...

2014-04-15 12:30:48

Major Production Increase Being Undertaken To Meet Growing Demand BETHESDA, Md., April 15, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced the closing of the first $15 million funding by a single institutional investor of the registered direct placement of up to $32 million which was announced by the Company last week. These first 2.27 million...

2014-04-15 08:30:06

Purchase adds global regulatory writing and submission services to Certara's drug development consulting expertise NEW YORK, April 15, 2014 /PRNewswire/ -- Arsenal Capital Partners, a leading New York based private equity firm that invests in middle market healthcare, specialty industrial, and financial services companies, announced today the acquisition of Synchrogenix, the leading regulatory writing and related services firm. Synchrogenix provides services to pharmaceutical,...

2014-04-14 12:34:19

DALLAS, April 14, 2014 /PRNewswire/ -- ReportsnReports.com offers Geriatric Medicine Development - Carving out New Opportunities to Treat Age-related Diseases 2014 market research report in its store at http://www.reportsnreports.com/reports/280698-geriatric-medicine-development-carving-out-new-opportunities-to-treat-age-related-diseases.html . Geriatric Medicine Development - Carving out New Opportunities to Treat Age-related Diseases report says despite the elderly...

2014-04-14 12:33:36

MST-188 decreased a marker of inflammation and red blood cell aggregation (50% reduction relative to control) SAN DIEGO, April 14, 2014 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) today announced that, in an ex vivo study conducted at Loyola University Medical Center, MST-188 reduced the mean erythrocyte sedimentation rate (ESR) by 50% relative to control in blood collected from individuals with sickle cell disease. ESR, a common laboratory test and measure of inflammation,...

2014-04-11 23:01:21

In an effort to reduce cancer health disparities among Asian-Americans, UC Davis Comprehensive Cancer Center now offers individual, in-language education and culturally sensitive materials for every Asian-American cancer patient. Sacramento, Calif. (PRWEB) April 11, 2014 In an effort to reduce cancer health disparities among Asian-Americans, UC Davis Comprehensive Cancer Center now offers individual, in-language education and culturally sensitive materials for every Asian-American cancer...

2014-04-11 08:24:12

ALBANY, New York, April 11, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Clinical Trial Management System Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2019," the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019. Browse Global...

2014-04-10 23:30:01

Verified Clinical Trials and ACRES form a strategic alliance to further the innovative systems-based solutions necessary to promote and facilitate research subject safety and improve data quality across the clinical trials industry. Verified Clinical Trials has pledged use of the research subject clinical trials database registry to stop dual enrollment in clinical trials to ACRES research sites. Cambridge, MA and Garden City, New York April 9, 2014 (PRWEB) April 10, 2014 Verified...